Bank of New York Mellon Corp - BALCHEM CORP ownership

BALCHEM CORP's ticker is BCPC and the CUSIP is 057665200. A total of 266 filers reported holding BALCHEM CORP in Q3 2021. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of BALCHEM CORP
ValueSharesWeighting
Q3 2023$37,393,787
-11.1%
301,466
-3.3%
0.01%
-11.1%
Q2 2023$42,041,084
+3.1%
311,854
-3.3%
0.01%0.0%
Q1 2023$40,773,910
+1.2%
322,374
-2.3%
0.01%0.0%
Q4 2022$40,307,506
-1.4%
330,092
-1.9%
0.01%
-10.0%
Q3 2022$40,894,000
-5.0%
336,342
+1.3%
0.01%0.0%
Q2 2022$43,061,000
-7.8%
331,901
-2.8%
0.01%
+11.1%
Q1 2022$46,702,000
-22.0%
341,637
-3.9%
0.01%
-18.2%
Q4 2021$59,909,000
+13.5%
355,334
-2.3%
0.01%
+10.0%
Q3 2021$52,767,000
+11.3%
363,740
+0.7%
0.01%
+11.1%
Q2 2021$47,411,000
+4.1%
361,204
-0.5%
0.01%0.0%
Q1 2021$45,540,000
+7.0%
363,133
-1.7%
0.01%0.0%
Q4 2020$42,545,000
+20.3%
369,255
+1.9%
0.01%0.0%
Q3 2020$35,367,000
-0.5%
362,259
-3.3%
0.01%0.0%
Q2 2020$35,537,000
-3.5%
374,631
+0.4%
0.01%
-25.0%
Q1 2020$36,836,000
-5.6%
373,138
-2.8%
0.01%
+20.0%
Q4 2019$39,033,000
-7.1%
384,070
-9.3%
0.01%
-16.7%
Q3 2019$42,009,000
-3.0%
423,529
-2.2%
0.01%0.0%
Q2 2019$43,290,000
+8.5%
433,039
+0.8%
0.01%
+9.1%
Q1 2019$39,887,000
+17.7%
429,810
-0.6%
0.01%0.0%
Q4 2018$33,887,000
-27.5%
432,497
+3.7%
0.01%
-8.3%
Q3 2018$46,734,000
+17.7%
416,938
+3.0%
0.01%
+9.1%
Q2 2018$39,715,000
+20.8%
404,678
+0.6%
0.01%
+22.2%
Q1 2018$32,879,000
+3.2%
402,190
+1.7%
0.01%
+12.5%
Q4 2017$31,869,000
-1.1%
395,403
-0.3%
0.01%
-11.1%
Q3 2017$32,237,000
+2.4%
396,579
-2.1%
0.01%0.0%
Q2 2017$31,471,000
-9.3%
404,966
-3.8%
0.01%
-10.0%
Q1 2017$34,697,000
+1.7%
420,978
+3.5%
0.01%0.0%
Q4 2016$34,122,000
+15.4%
406,598
+6.7%
0.01%
+11.1%
Q3 2016$29,557,000
+35.3%
381,231
+4.1%
0.01%
+28.6%
Q2 2016$21,852,000
-10.5%
366,376
-7.0%
0.01%0.0%
Q1 2016$24,428,000
+4.1%
393,889
+2.1%
0.01%0.0%
Q4 2015$23,462,000
+4.5%
385,896
+4.5%
0.01%0.0%
Q3 2015$22,443,000
+22.8%
369,295
+12.6%
0.01%
+40.0%
Q2 2015$18,276,000
+3.4%
328,008
+2.8%
0.01%0.0%
Q1 2015$17,676,000
-42.1%
319,174
-30.3%
0.01%
-37.5%
Q4 2014$30,527,000
+12.0%
458,101
-4.9%
0.01%
+14.3%
Q3 2014$27,256,000
-49.7%
481,807
-52.3%
0.01%0.0%
Q2 2014$54,150,000
+106.7%
1,011,030
+101.2%
0.01%0.0%
Q1 2014$26,195,000
+30.6%
502,610
+47.1%
0.01%
+16.7%
Q4 2013$20,052,000
-44.9%
341,575
-51.4%
0.01%
+20.0%
Q3 2013$36,404,000
+83.8%
703,422
+58.9%
0.01%
-16.7%
Q2 2013$19,807,000442,5980.01%
Other shareholders
BALCHEM CORP shareholders Q3 2021
NameSharesValueWeighting ↓
SANTA MONICA PARTNERS LP 425,686$49,048,00036.25%
Conestoga Capital Advisors, LLC 939,134$108,207,0001.72%
Tributary Capital Management, LLC 197,207$22,722,0001.63%
Ellsworth Advisors, LLC 16,335$1,882,0001.36%
GENEVA CAPITAL MANAGEMENT LLC 693,677$79,926,0001.35%
Brown Capital Management 1,391,418$160,319,0001.11%
BARD ASSOCIATES INC 107,550$12,390,0000.98%
Advantage Alpha Capital Partners LP 38,370$4,421,0000.97%
MOODY ALDRICH PARTNERS LLC 50,270$5,792,0000.94%
Cutter & CO Brokerage, Inc. 29,369$3,384,0000.89%
View complete list of BALCHEM CORP shareholders